Method for the treatment of constipation

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 8,771,760
App. No.: 13/093,911
Granted: Jul 8, 2014
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.

Claims (1)

1. A method of treatment of constipation comprising administering to a subject in need thereof a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), wherein the ratio of CBD:THC by weight is between 10:1 and 1:10, wherein the constipation is associated with opiate or opiate related drug therapy.

Assignments (6)

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2026

From: JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED; JAZZ PHARMACEUTICALS RESEARCH UK LIMITED

To: CNX THERAPEUTICS LIMITED

Reel/Frame 073691/0141 →

RELEASE OF SECURITY INTEREST Recorded Oct 31, 2025

From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION

To: JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED (F/K/A GW PHARMA LIMITED); JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (F/K/A GW RESEARCH LIMITED)

Reel/Frame 072747/0876 →

CHANGE OF NAME Recorded May 13, 2025

From: GW RESEARCH LIMITED

To: JAZZ PHARMACEUTICALS RESEARCH UK LIMITED